Literature DB >> 21928277

Unravelling the T-cell-mediated autoimmune attack on CNS myelin in a new primate EAE model induced with MOG34-56 peptide in incomplete adjuvant.

S Anwar Jagessar1, Nicole Heijmans, Erwin L A Blezer, Jan Bauer, Jeroen H Blokhuis, Jacqueline A M Wubben, Jan W Drijfhout, Peter J van den Elsen, Jon D Laman, Bert A 't Hart.   

Abstract

Induction of experimental autoimmune encephalomyelitis (EAE) has been documented in common marmosets using peptide 34-56 from human myelin/oligodendrocyte glycoprotein (MOG(34-56) ) in incomplete Freund's adjuvant (IFA). Here, we report that this EAE model is associated with widespread demyelination of grey and white matter. We performed an in-depth analysis of the specificity, MHC restriction and functions of the activated T cells in the model, which likely cause EAE in an autoantibody-independent manner. T-cell lines isolated from blood and lymphoid organs of animals immunized with MOG(34-56) displayed high production of IL-17A and specific lysis of MOG(34-56) -pulsed EBV B-lymphoblastoid cells as typical hallmarks. Cytotoxicity was directed at the epitope MOG(40-48) presented by the non-classical MHC class Ib allele Caja-E, which is orthologue to HLA-E and is expressed in non-inflamed brain. In vivo activated T cells identified by flow cytometry in cultures with MOG(34-56,) comprised CD4(+) CD56(+) and CD4(+) CD8(+) CD56(+) T cells. Furthermore, phenotypical analysis showed that CD4(+) CD8(+) CD56(+) T cells also expressed CD27, but CD16, CD45RO, CD28 and CCR7 were absent. These results show that, in the MOG34-56/IFA marmoset EAE model, a Caja-E-restricted population of autoreactive cytotoxic T cells plays a key role in the process of demyelination in the grey and white matter.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21928277     DOI: 10.1002/eji.201141863

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  23 in total

1.  Immune modulation by a tolerogenic myelin oligodendrocyte glycoprotein (MOG)10-60 containing fusion protein in the marmoset experimental autoimmune encephalomyelitis model.

Authors:  Y S Kap; N van Driel; R Arends; G Rouwendal; M Verolin; E Blezer; N Lycke; B A 't Hart
Journal:  Clin Exp Immunol       Date:  2015-04       Impact factor: 4.330

2.  The repertoire of MHC class I genes in the common marmoset: evidence for functional plasticity.

Authors:  Marit K van der Wiel; Nel Otting; Natasja G de Groot; Gaby G M Doxiadis; Ronald E Bontrop
Journal:  Immunogenetics       Date:  2013-09-10       Impact factor: 2.846

3.  Lymphocryptovirus Infection of Nonhuman Primate B Cells Converts Destructive into Productive Processing of the Pathogenic CD8 T Cell Epitope in Myelin Oligodendrocyte Glycoprotein.

Authors:  S Anwar Jagessar; Inge R Holtman; Sam Hofman; Elena Morandi; Nicole Heijmans; Jon D Laman; Bruno Gran; Bart W Faber; Sander I van Kasteren; Bart J L Eggen; Bert A 't Hart
Journal:  J Immunol       Date:  2016-07-13       Impact factor: 5.422

4.  The different clinical effects of anti-BLyS, anti-APRIL and anti-CD20 antibodies point at a critical pathogenic role of γ-herpesvirus infected B cells in the marmoset EAE model.

Authors:  S Anwar Jagessar; Zahra Fagrouch; Nicole Heijmans; Jan Bauer; Jon D Laman; Luke Oh; Thi Migone; Ernst J Verschoor; Bert A 't Hart
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-19       Impact factor: 4.147

5.  In vivo immunogenicity of Tax(11-19) epitope in HLA-A2/DTR transgenic mice: implication for dendritic cell-based anti-HTLV-1 vaccine.

Authors:  Divya Sagar; Shet Masih; Todd Schell; Steven Jacobson; Joseph D Comber; Ramila Philip; Brian Wigdahl; Pooja Jain; Zafar K Khan
Journal:  Vaccine       Date:  2014-04-13       Impact factor: 3.641

Review 6.  Experimental autoimmune encephalomyelitis in the common marmoset: a translationally relevant model for the cause and course of multiple sclerosis.

Authors:  Bert A 't Hart
Journal:  Primate Biol       Date:  2019-05-10

7.  Antibodies against human BLyS and APRIL attenuate EAE development in marmoset monkeys.

Authors:  S Anwar Jagessar; Nicole Heijmans; Luke Oh; Jan Bauer; Erwin L A Blezer; Jon D Laman; Thi-Sau Migone; Matt N Devalaraja; Bert A 't Hart
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-30       Impact factor: 4.147

8.  Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant.

Authors:  S Anwar Jagessar; Nicole Heijmans; Erwin L A Blezer; Jan Bauer; Robert Weissert; Bert A 't Hart
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

9.  The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis.

Authors:  Bert A 't Hart; S Anwar Jagessar; Krista Haanstra; Ernst Verschoor; Jon D Laman; Yolanda S Kap
Journal:  Front Immunol       Date:  2013-06-13       Impact factor: 7.561

Review 10.  Multiple sclerosis and drug discovery: A work of translation.

Authors:  Bert A 't Hart; Antonio Luchicchi; Geert J Schenk; Joep Killestein; Jeroen J G Geurts
Journal:  EBioMedicine       Date:  2021-05-24       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.